491 related articles for article (PubMed ID: 34292611)
1. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
[TBL] [Abstract][Full Text] [Related]
2. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
Johnston MS; Galan A; Watsky KL; Little AJ
JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
[TBL] [Abstract][Full Text] [Related]
3. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).
Sandhu S; Bhatnagar A; Kumar H; Dixit PK; Paliwal G; Suhag DK; Patil C; Mitra D
Dermatol Ther; 2021 Nov; 34(6):e15141. PubMed ID: 34546608
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE
J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079
[TBL] [Abstract][Full Text] [Related]
5. Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study.
Papadimitriou I; Bakirtzi K; Sotiriou E; Vakirlis E; Hatzibougias D; Ioannides D
Clin Exp Dermatol; 2022 Jan; 47(1):157-158. PubMed ID: 34288056
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE
J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.
Ohsawa R; Sano H; Ikeda M; Sano S
J Dermatol Sci; 2021 Aug; 103(2):124-127. PubMed ID: 34167874
[No Abstract] [Full Text] [Related]
9. Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance.
Kharkar V; Vishwanath T; Mahajan S; Joshi R; Gole P
Clin Exp Dermatol; 2021 Dec; 46(8):1596-1597. PubMed ID: 34115904
[No Abstract] [Full Text] [Related]
10. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects.
Pham MN; Murugesan K; Banaei N; Pinsky BA; Tang M; Hoyte E; Lewis DB; Gernez Y
J Allergy Clin Immunol; 2022 Mar; 149(3):907-911.e3. PubMed ID: 34952033
[TBL] [Abstract][Full Text] [Related]
11. Defining urticarial dermatitis: a subset of dermal hypersensitivity reaction pattern.
Kossard S; Hamann I; Wilkinson B
Arch Dermatol; 2006 Jan; 142(1):29-34. PubMed ID: 16415383
[TBL] [Abstract][Full Text] [Related]
12. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A
Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
[TBL] [Abstract][Full Text] [Related]
15. Histopathological Spectrum of Cutaneous Reactions following COVID-19 Vaccine - An Observational Study.
Mohta A; Nyati A; Mohta A; Ghiya BC; Mehta RD; Kumar V
Indian Dermatol Online J; 2023; 14(2):207-212. PubMed ID: 37089846
[TBL] [Abstract][Full Text] [Related]
16. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
18. Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy.
Cazzato G; Ambrogio F; Pisani MC; Colagrande A; Arezzo F; Cascardi E; Dellino M; Macorano E; Trilli I; Parente P; Lettini T; Romita P; Marzullo A; Ingravallo G; Foti C
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851273
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review.
Abdelmaksoud A; Wollina U; Temiz SA; Hasan A
Dermatol Ther; 2022 Jun; 35(6):e15458. PubMed ID: 35306713
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
Qaderi K; Golezar MH; Mardani A; Mallah MA; Moradi B; Kavoussi H; Shamsabadi A; Golezar S
Dermatol Ther; 2022 May; 35(5):e15391. PubMed ID: 35194894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
